Egon Zehnder
Search
Select region
Close filter
Board Advisory

The Path to the Boardroom

A practical guide to landing your first corporate board seat


Your journey starts here.

The Path to the Boardroom is a three-part series of Executive Briefings designed to help first-time aspirants for a board seat negotiate the difficult route to success.

Drawing on our work with 600+ boards annually, we created a real-world guide to help you find your first corporate directorship. From starting your search, to interviewing for a directorship, to getting off to a good start as a new board member, this guide will prepare you to confidently take a seat at the boardroom table.

The Opportunities to Serve

Finding a board seat is akin to a job search. It takes time and effort to find the right fit, and there are more qualified candidates than there are board seats. But more opportunities are becoming available. 

  • 428 new directors elected to S&P 500 boards in 2018--the largest number of new directors since 2004

  • 65% of directors named to boards in 2018 were not C-suite executives

 

Read the full three-step guide to landing your first corporate board seat.

Topics Related to this Article

Related content

How Boards Are Handling ESG

How Boards Are Handling ESG

Board Advisory

Nominating and governance committee chairs weigh in on how the boards should handle ESG. Read more

Creating Opportunities While Weathering a Crisis

Creating Opportunities While Weathering a Crisis

Consumer

Egon Zehnder gathered Chinese executives and US public board members on May 14th to exchange their experiences and share their outlook for the future. Read more

Efectividad de los Directorios en Argentina

Efectividad de los Directorios en Argentina

Board Advisory

Los factores que determinan la efectividad de un Directorio. Read more

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top